Department of Endocrinology and Metabolism, Faculty of Medicine, Amasya University, Amasya, Turkey.
Department of Endocrinology and Metabolism, Gazi State Hospital, Samsun, Turkey.
Int J Clin Pract. 2021 May;75(5):e14003. doi: 10.1111/ijcp.14003. Epub 2021 Jan 21.
Thyroid ultrasound, thyroid scintigraphy and radioactive iodine uptake (RAIU) tests are helpful in the differential diagnosis of thyrotoxicosis and hyperthyroidism. In the setting where these techniques are unavailable or unusable more accessible, and cheaper techniques would be helpful.
We evaluated the capability of free triiodothyronine to free thyroxine ratio (FT3/FT4) to differentiate Graves' Disease (GD) and destructive thyroiditis (DT).
In total, 318 patients with GD and 140 patients with DT were included in the study. Patients were assigned to two groups: GD and DT (subacute thyroiditis, painless thyroiditis, postpartum thyroiditis). Serum thyroid-stimulating hormone (TSH), FT4, FT3 levels and FT3/FT4 ratio were evaluated in each group. To obtain the optimal diagnostic cut-off value of FT3, FT4 and FT3/FT4 ratio, ROC curve analysis was performed of all untreated thyrotoxicosis patients.
The optimal FT3/FT4 ratio cut-off value was 2.96, with a sensitivity of 71.7%, the specificity of 88.6%. The area under the ROC curve of the FT3/FT4 ratio regarding the diagnosis of GD was 0.864 (95% CI: 0.830-0.894). The cut-off level of FT3 for GD was determined as 6.6 pg/mL which had a sensitivity of 72.3% and specificity of 68.6% (AUC = 0.771 P < .001). The cut-off level of FT4 for GD was determined as 3.65 ng/dl with a sensitivity of 35.5% and specificity of 83.6% (AUC = 0.615 P < .001). When a high specificity is needed, FT3/FT4 cut-off value increases to 3.63 with 99.3% specificity and 36.5% sensitivity.
FT3/FT4 ratio helps distinguish GD and DT. In cases of situations where RAIU/scintigraphy and TRAb cannot be studied, the FT3/FT4 ratio is a viable diagnostic tool. Cut-off values with higher specificity can be more helpful in differential diagnosis of GD.
甲状腺超声、甲状腺闪烁扫描和放射性碘摄取(RAIU)检查有助于鉴别甲状腺毒症和甲亢。在这些技术不可用或不可用时,更易获得且更便宜的技术将有所帮助。
我们评估游离三碘甲状腺原氨酸与游离甲状腺素比值(FT3/FT4)在鉴别格雷夫斯病(GD)和破坏性甲状腺炎(DT)中的作用。
共纳入 318 例 GD 患者和 140 例 DT 患者。患者被分为两组:GD 和 DT(亚急性甲状腺炎、无痛性甲状腺炎、产后甲状腺炎)。评估各组的血清促甲状腺激素(TSH)、FT4、FT3 水平和 FT3/FT4 比值。为了获得所有未经治疗的甲状腺毒症患者的最佳 FT3、FT4 和 FT3/FT4 比值诊断截断值,对所有未经治疗的甲状腺毒症患者进行 ROC 曲线分析。
最佳 FT3/FT4 比值截断值为 2.96,敏感性为 71.7%,特异性为 88.6%。FT3/FT4 比值对 GD 诊断的 ROC 曲线下面积为 0.864(95%CI:0.830-0.894)。GD 的 FT3 截断值为 6.6pg/mL,敏感性为 72.3%,特异性为 68.6%(AUC=0.771,P<.001)。GD 的 FT4 截断值为 3.65ng/dl,敏感性为 35.5%,特异性为 83.6%(AUC=0.615,P<.001)。当需要高特异性时,FT3/FT4 截断值增加至 3.63,特异性为 99.3%,敏感性为 36.5%。
FT3/FT4 比值有助于鉴别 GD 和 DT。在无法进行 RAIU/闪烁扫描和 TRAb 研究的情况下,FT3/FT4 比值是一种可行的诊断工具。具有更高特异性的截断值在 GD 的鉴别诊断中可能更有帮助。